Thus, CypD KO has no effect on liver fibrosis in this model, suggesting that the decrease in fibrosis previously observed with pan-cyclophilin inhibitor compounds NV556 and CRV431 came as a result of the inhibition of cyclophilin family members other than CypD. Here, PPIB is linked to Hepatic fibrosis.